Market research
XFAB.PA X-FAB Silicon Foundries SE
PA EUR Technology
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 773M
- P/E ratio
- 197.33
- Analyst target
- 7.4274
- Dividend yield
- Not available
- Beta
- 1.49
Profile
Company facts
- Exchange
- PA
- Currency
- EUR
- Sector
- Technology
- Industry
- Semiconductors
- ISIN
- BE0974310428
- Market cap
- 773M
- P/E ratio
- 197.33
- Analyst target
- 7.4274
- Dividend yield
- Not available
- Beta
- 1.49
About
About X-FAB Silicon Foundries SE
X-FAB Silicon Foundries SE develops, produces, and sells analog/mixed-signal IC, micro-electro-mechanical systems, and silicon photonics products for automotive, medical, industrial, communication, and consumer sectors in the Europe, the United States, Asia, and internationally. The company offers silicon carbide and gallium nitride; avalanche photodiodes and single-photon avalanche diodes; gas and flow, image, inertial, pressure, photodiodes, and temperature sensors. It also provides wafer fabrication, design support and IP libraries, customer-specific technologies development; non-recurring engineering and technology; outsourcing and fab transfers services. X-FAB Silicon Foundries SE was founded in 1992 and is based in Tessenderlo, Belgium.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the XFAB.PA discussion.
5 years, 4 months ago
X-FAB Silicon Foundries SE is currently in a long term uptrend where the price is trading 22.1% above its 200 day moving average.
From a valuation standpoint, the stock is 36.7% cheaper than other stocks from the Technology sector with a price to sales ratio of 2.2.
X-FAB Silicon Foundries SE's total revenue sank by 0.0% to $113M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-22M since the same quarter in the previous year.
Finally, its free cash flow grew by 321.8% to $18M since the same quarter in the previous year.
Based on the above factors, X-FAB Silicon Foundries SE gets an overall score of 3/5.